Course: Enhancing the Continuum of Care for Early Alzheimer’s Disease in Rural and Underserved Communities: The Role of Specialists
CME Credits: 0.00
Released: 2025-01-31
An estimated 6.7 million Americans aged 65 years and older are currently living with Alzheimer’s disease (AD), and over 11 million cases are projected by 2040. Diagnosis of AD is often delayed until later in the disease course, particularly in rural and underserved areas where access to care may be limited. Thus, it is critical that specialists who serve these populations be familiar with the risk factors, progression, and treatment options for AD to optimize patient care and outcomes. In this CME/CE activity, expert faculty will provide updates on the latest therapeutic advances, including disease-modifying therapies (DMTs) and their role in AD management. Strategies for collaborating with primary care clinicians to improve care and outcomes in rural and underserved settings will also be discussed. The content for this enduring activity was recorded on January 13, 2025.
Upon completion of this activity, participants should be better able to:
View Full Course